Trials / Completed
CompletedNCT00873184
Study of Massage Therapy Within a Brain Tumor Setting
Feasibility Study of Massage Therapy Within a Brain Tumor Setting
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is * to assess the feasibility and acceptability of massage therapyto examine the effects of massage therapy * to explore whether psychological outcomes are associated with changes in patient reported QoL.
Detailed description
As a part of this study, we will provide massage therapy to brain tumor patients. Our contribution here is expected to determine whether massage therapy is safe and helps to improve patient QoL. This contribution is significant because it is expected to provide pilot data on effect sizes so that we may design an adequately powered study to develop massage therapy programs and interventions for patients with brain tumors. In addition to benefiting brain tumor patients, the information from this study may be applied to improving the QoL of other cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Massage Therapy | The setting for massage intervention will take place at The Duke Center for Living (DCL). . The massage therapists at the DCL work closely with physicians to design appropriate interventions for patients who are receiving treatment at DUMC, including cancer patients. All DCL therapists have completed more than 600 hours of training, are nationally certified and hold a North Carolina license to practice massage. These types include Swedish, deep muscle, myofascial release, trigger point, acupressure, Bowen Technique, sports massage and chair massage. |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-04-01
- Last updated
- 2013-05-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00873184. Inclusion in this directory is not an endorsement.